Drugs and biologicals
Ended Awarded
- Contract number
- HHSN26300204
- Awardee
-
Pierce Biotechnology Inc. UEI CCSJMTEVB1V7 Part of Thermo Electron Corporation
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,608
Award facts
- Contract value 50% obligated
-
- $3,608.00 Current, with exercised options
- $7,216.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Fixed Price Level of Effort
- Place of performance
- Rockford, IL 61105, USA
Award details come from SAM.gov/FPDS.
About this award
Pierce Biotechnology Inc., a subsidiary of Thermo Electron Corporation, received a federal contract award on August 20, 2012, from the Office of the Director (civilian agency) for drugs and biologicals under a Blanket Purchase Agreement (BPA) call structure. This fixed-price, level-of-effort contract carries a ceiling value of $7,216 and is scheduled for ultimate completion on February 28, 2013, with performance conducted in Rockford, Illinois. No set-aside designation was applied to this award.
As a child entity of Thermo Electron Corporation, Pierce Biotechnology provides scientific instruments and related services aligned with its parent company's expertise in analytical equipment and laboratory instrumentation. Thermo Electron has established itself as a significant federal supplier across multiple agencies including the Department of Health and Human Services, Department of Defense, and the Environmental Protection Agency, delivering specialized equipment such as mass spectrometers, chromatography systems, and related analytical devices. This particular BPA call represents a task order against an existing indefinite delivery vehicle, allowing the government agency to procure required biologicals and pharmaceutical-related products or services efficiently without requiring a new competitive solicitation.
Quick answers
Who was awarded contract HHSN26300204?
HHSN26300204 was awarded to Pierce Biotechnology Inc. by Office of the Director (National Institutes of Health) on August 20, 2012.
How much is contract HHSN26300204 worth?
The government has obligated $3,608 on HHSN26300204. Its potential value, with all options, is $7,216.
Is contract HHSN26300204 an order under another contract?
Yes. HHSN26300204 is a BPA call under HHSN263199800049380B, a blanket purchase agreement.
Was contract HHSN26300204 competed?
The extent of competition for HHSN26300204 was competed under sap. The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award